| Erica Rene Wilt, MD | |
|
11215 Metro Pkwy Ste 100, Fort Myers, FL 33966-1206 | |
| (239) 208-2206 | |
| Not Available |
| Full Name | Erica Rene Wilt |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 11 Years |
| Location | 11215 Metro Pkwy Ste 100, Fort Myers, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003253857 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| High Point Regional Health System | High point, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wake Forest University Health Sciences | 4486564952 | 1987 |
News Archive
ZELTIQ, a California-based developer of ground-breaking non-invasive fat reduction technology, today announces that it has raised $25 million in Series D funding. Aisling Capital led the round and was joined by returning investors Advanced Technology Ventures, Frazier Healthcare Ventures and Venrock. Since being formed in 2005, ZELTIQ has raised approximately $50 million.
During pregnancy, women are normally advised to take high amounts of multivitamin supplements. In particular, folate is recommended to reduce the risk of neural tube defects in newborns. The problem is that, although vitamins are critical in fetal development, high vitamin doses during pregnancy may cause undesired effects on the offspring later in life.
The chemotherapy regimen of doxorubicin plus docetaxel, used to treat breast cancer in a clinical trial, was associated with an increased risk of serious complications, resulting in the premature termination of the trial, according to a study in the May 18 issue of JAMA.
The New York Times reports on health in the U.S. "The percentage of people who reported having excellent or very good health declined to 66.6 percent in the 2009 period, from 69.1 percent in 1998.
› Verified 2 days ago
| Entity Name | Wake Forest University Health Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003803032 PECOS PAC ID: 4486564952 Enrollment ID: O20031105000436 |
News Archive
ZELTIQ, a California-based developer of ground-breaking non-invasive fat reduction technology, today announces that it has raised $25 million in Series D funding. Aisling Capital led the round and was joined by returning investors Advanced Technology Ventures, Frazier Healthcare Ventures and Venrock. Since being formed in 2005, ZELTIQ has raised approximately $50 million.
During pregnancy, women are normally advised to take high amounts of multivitamin supplements. In particular, folate is recommended to reduce the risk of neural tube defects in newborns. The problem is that, although vitamins are critical in fetal development, high vitamin doses during pregnancy may cause undesired effects on the offspring later in life.
The chemotherapy regimen of doxorubicin plus docetaxel, used to treat breast cancer in a clinical trial, was associated with an increased risk of serious complications, resulting in the premature termination of the trial, according to a study in the May 18 issue of JAMA.
The New York Times reports on health in the U.S. "The percentage of people who reported having excellent or very good health declined to 66.6 percent in the 2009 period, from 69.1 percent in 1998.
› Verified 2 days ago
| Entity Name | Telespecialists North Carolina Neurology Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245926138 PECOS PAC ID: 7719348978 Enrollment ID: O20230803002841 |
News Archive
ZELTIQ, a California-based developer of ground-breaking non-invasive fat reduction technology, today announces that it has raised $25 million in Series D funding. Aisling Capital led the round and was joined by returning investors Advanced Technology Ventures, Frazier Healthcare Ventures and Venrock. Since being formed in 2005, ZELTIQ has raised approximately $50 million.
During pregnancy, women are normally advised to take high amounts of multivitamin supplements. In particular, folate is recommended to reduce the risk of neural tube defects in newborns. The problem is that, although vitamins are critical in fetal development, high vitamin doses during pregnancy may cause undesired effects on the offspring later in life.
The chemotherapy regimen of doxorubicin plus docetaxel, used to treat breast cancer in a clinical trial, was associated with an increased risk of serious complications, resulting in the premature termination of the trial, according to a study in the May 18 issue of JAMA.
The New York Times reports on health in the U.S. "The percentage of people who reported having excellent or very good health declined to 66.6 percent in the 2009 period, from 69.1 percent in 1998.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erica Rene Wilt, MD 624 Quaker Ln Ste D201, High Point, NC 27262-3832 Ph: (336) 781-4065 | Erica Rene Wilt, MD 11215 Metro Pkwy Ste 100, Fort Myers, FL 33966-1206 Ph: (239) 208-2206 |
News Archive
ZELTIQ, a California-based developer of ground-breaking non-invasive fat reduction technology, today announces that it has raised $25 million in Series D funding. Aisling Capital led the round and was joined by returning investors Advanced Technology Ventures, Frazier Healthcare Ventures and Venrock. Since being formed in 2005, ZELTIQ has raised approximately $50 million.
During pregnancy, women are normally advised to take high amounts of multivitamin supplements. In particular, folate is recommended to reduce the risk of neural tube defects in newborns. The problem is that, although vitamins are critical in fetal development, high vitamin doses during pregnancy may cause undesired effects on the offspring later in life.
The chemotherapy regimen of doxorubicin plus docetaxel, used to treat breast cancer in a clinical trial, was associated with an increased risk of serious complications, resulting in the premature termination of the trial, according to a study in the May 18 issue of JAMA.
The New York Times reports on health in the U.S. "The percentage of people who reported having excellent or very good health declined to 66.6 percent in the 2009 period, from 69.1 percent in 1998.
› Verified 2 days ago
Stanley Garken Lue, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 11215 Metro Pkwy Ste 1, Fort Myers, FL 33966 Phone: 239-208-2212 Fax: 239-208-3994 | |
Felix Gabriel Rivera - Perez, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 11215 Metro Pkwy Ste 1, Fort Myers, FL 33966 Phone: 239-208-2212 | |
Ellie Frazey, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 11215 Metro Pkwy Ste 1, Fort Myers, FL 33966 Phone: 239-208-2212 | |
Dr. Mark Adam Giordano, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 12550 New Brittany Blvd Ste 100, Fort Myers, FL 33907 Phone: 239-343-9180 Fax: 239-343-9188 | |
Gustavo Silveira E Silva, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 11215 Metro Pkwy Ste 100, Fort Myers, FL 33966 Phone: 239-208-2206 | |
Dr. Deepa Vaduthalakuzhy Luka, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 15901 Bass Rd Ste 108, Fort Myers, FL 33908 Phone: 239-343-6050 Fax: 239-343-6051 |